Onsdag 28 Oktober | 18:57:06 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

OssDsign Q1 - An undramatic first quarter

2022-05-25 10:00:00

Redeye regards OssDsign’s Q1 as a relative non-event quarter; elective surgeries took a major toll in the early months of Q1, but the lower-than-anticipated sales for OssDsign do not render any case reconsiderations, we argue.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/